Compare SVRA & BRBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SVRA | BRBR |
|---|---|---|
| Founded | 2007 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2009 | 2019 |
| Metric | SVRA | BRBR |
|---|---|---|
| Price | $5.28 | $11.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 17 |
| Target Price | $7.33 | ★ $36.63 |
| AVG Volume (30 Days) | 1.6M | ★ 4.2M |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.95 |
| Revenue | N/A | ★ $2,316,600,000.00 |
| Revenue This Year | N/A | $6.28 |
| Revenue Next Year | $430.87 | $5.81 |
| P/E Ratio | ★ N/A | $11.57 |
| Revenue Growth | N/A | ★ 16.05 |
| 52 Week Low | $2.92 | $7.82 |
| 52 Week High | $7.01 | $43.02 |
| Indicator | SVRA | BRBR |
|---|---|---|
| Relative Strength Index (RSI) | 41.84 | 38.64 |
| Support Level | $4.77 | $10.16 |
| Resistance Level | $5.43 | $14.23 |
| Average True Range (ATR) | 0.28 | 0.86 |
| MACD | -0.00 | -0.28 |
| Stochastic Oscillator | 11.73 | 21.42 |
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
BellRing Brands Inc is a United States-based company engaged in providing nutrition-related products. Its brands, Premier Protein, Dymatize, and PowerBar provides various products including ready-to-drink protein shakes, powders and nutrition bars. The company's products are distributed through a diverse network of channel including club, food, drug and mass, eCommerce, convenience and specialty.